ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IBT International Biotechnology Trust Plc

680.00
-2.00 (-0.29%)
Last Updated: 10:13:24
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
International Biotechnology Trust Plc LSE:IBT London Ordinary Share GB0004559349 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.00 -0.29% 680.00 678.00 682.00 682.00 680.00 682.00 20,631 10:13:24
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Trust,ex Ed,religious,charty 12.06M 6.81M 0.1858 36.60 250.09M

Intl. Biotechnology Trust PLC Transaction in Own Shares

15/08/2024 5:06pm

RNS Regulatory News


RNS Number : 6622A
Intl. Biotechnology Trust PLC
15 August 2024
 

Transaction in own shares

International Biotechnology Trust plc (the "Company") announces that on Thursday 15 August 2024 it purchased 15,000 of its ordinary shares at a price of 688 pence per share, to be held in treasury.

Following this purchase, the Company's issued share capital consists of 41,383,817 ordinary shares of 25p each, the total number of shares in treasury is 4,508,907 and the total number of voting rights in the Company is 36,874,910.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Enquiries:

Schroder Investment Management Limited

Tel: 020 7658 6000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQELFFZVLBBBE

1 Year International Biotechnol... Chart

1 Year International Biotechnol... Chart

1 Month International Biotechnol... Chart

1 Month International Biotechnol... Chart

Your Recent History

Delayed Upgrade Clock